Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Some natural compounds can protect fish ear cells from damage by certain antibiotics without affecting the antibiotics' ability to fight infections.

The new fluoroquinolone effectively fights certain bacteria.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Quinoline alkaloids from Cinchona may help treat cancer, diabetes, fungal infections, and promote hair growth.

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

Some people experience severe, long-lasting side effects from fluoroquinolone antibiotics, leading to the recommendation of limited use and increased awareness of these risks.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Benzalkonium chloride effectively treats skin fungus in guinea pigs.

Measuring OPC-17116 in hair can reliably indicate drug exposure and timing.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.